Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...

In its order, CJ Upadhyaya-led bench directed PIL litigant to submit to CDSCO the scientific studies and data relied upon in ...

Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...

Delhi High Court asks DCGI to consult experts on weight-loss drug combinations, addressing concerns over safety and approval ...